Intensity Therapeutics, Inc. Common stock (NASDAQ: INTS) — Healthcare · Share Price, Chart & Market Data
About: Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.25 (-1.50%)
INTSIntensity Therapeutics, Inc. Common stock
Loading watchlist status…
Trade INTS now
Intensity Therapeutics, Inc. Common stock share price
INTS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:51 am GMT+0
INTS price performance
0.671%
5D
-11.318%
1M
-48.403%
YTD
-76.669%
1Y
INTS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:51 am GMT+0
INTS details
INTS Market Signals